Admission Date:  [**2103-2-7**]              Discharge Date:   [**2103-2-13**]  Date of Birth:  [**2039-11-15**]             Sex:   M  Service: MEDICINE  Allergies: Hydralazine  Attending:[**First Name3 (LF) 477**] Chief Complaint: Dysphagia/inability to swallow liquids or solids  Major Surgical or Invasive Procedure: EGD with stent placement   History of Present Illness: Pt is a 63 YO M with progressive esophageal cancer on 3rd line chemo, xeloda, presenting with 4 day hx of progressive difficulty swollowing first solids, now liquids.
Family History: N/C  Physical Exam: vs - T 98.5 BP 155/86 HR 78 RR 22 94%RA gen- a+ox3, nad heent - eomi, perrl, mmm, no oral lesions or thrush neck - supple, no LAD cor - rrr, no murmurs chest - cta b abd - mild tend to deep palpation at periumbilical area, otherwise pain free, no palpated hernia, non-distended ext - w/wp, no edema   Pertinent Results: Initial labs:  [**2103-2-7**] 06:30PM   PT-14.2* PTT-27.1 INR(PT)-1.3* [**2103-2-7**] 06:30PM   PLT COUNT-124* [**2103-2-7**] 06:30PM   ANISOCYT-2+ MACROCYT-3+ [**2103-2-7**] 06:30PM   NEUTS-79.9* LYMPHS-14.0* MONOS-5.5 EOS-0.4 BASOS-0.1 [**2103-2-7**] 06:30PM   WBC-5.4 RBC-2.96* HGB-10.8* HCT-31.2* MCV-105* MCH-36.4* MCHC-34.5 RDW-21.0* [**2103-2-7**] 06:30PM   CALCIUM-9.3 PHOSPHATE-3.5 MAGNESIUM-1.7 [**2103-2-7**] 06:30PM   LIPASE-164* [**2103-2-7**] 06:30PM   ALT(SGPT)-16 AST(SGOT)-21 ALK PHOS-92 AMYLASE-110* TOT BILI-0.8 [**2103-2-7**] 06:30PM   GLUCOSE-101 UREA N-12 CREAT-1.1 SODIUM-140 POTASSIUM-3.8 CHLORIDE-104 TOTAL CO2-27 ANION GAP-13  Discharge labs:  [**2103-2-13**] 12:00AM BLOOD WBC-6.3 RBC-2.56* Hgb-9.5* Hct-27.2* MCV-106* MCH-37.1* MCHC-34.8 RDW-18.7* Plt Ct-106* [**2103-2-9**] 12:00AM BLOOD Neuts-67.3 Lymphs-21.5 Monos-8.4 Eos-2.5 Baso-0.2 [**2103-2-13**] 12:00AM BLOOD Plt Ct-106* [**2103-2-13**] 12:00AM BLOOD Glucose-101 UreaN-11 Creat-1.1 Na-132* K-3.8 Cl-99 HCO3-24 AnGap-13 [**2103-2-13**] 12:00AM BLOOD ALT-38 AST-50* LD(LDH)-215 AlkPhos-144* Amylase-51 TotBili-1.0 [**2103-2-13**] 12:00AM BLOOD Calcium-8.4 Phos-3.7 Mg-1.8 [**2103-2-12**] 12:00AM BLOOD TSH-3.0  Imaging:  [**2-7**] CXR negative [**2-8**] CT abd/pelvis: 1.
Pathologically enlarged paraaortic and periportal lymph nodes identified on recent PET-CT to show increased FDG avidity consistent with pathologic involvement.
Ct abdomen shows no pancreatic duct dilation and amylase and lipase trended down.
Patient treated with oxycodone and oxycontin for pain control.
As he has known esophageal cancer, GI was consulted for stent which was placed on [**2103-2-9**].
The day after the procedure, pt tolerated liquids and soft diet which he should continue.
The patient had sscp after the procedure worse with movement.
It was not clear if this pain was present prior to the procedure and just worsened by it.
He was controlled with miracle mouth wash, oxycontin and oxycodone.
#Pruritis- patient had rash on chest and back and this was thought to be due to hydralazine which was started and stopped that day.
We treated patient with sarna lotion and benadryl.
On admission, patient was orthostatic and responded to fluid bolus both blood pressure wise and symptomatically.
Patient not on any medications that cause orthostasis.
We encouraged patient to take in plenty of liquids at home.
Patient was continued on celexa, alprazolam and risperdal.
# BPH - proscar   Medications on Admission: lipitor 20 mg QD celexa  40 mg QD xanax  prn risperidal 1 mg QHS proscar 5 mg QHS oxycodone prn   Discharge Medications: 1.
Senna 8.8 mg/5 mL Syrup Sig: One (1) Tablet PO BID (2 times a day) as needed.
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Finasteride 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atorvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Alprazolam 0.25 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Risperidone 1 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Citalopram 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Fexofenadine 60 mg Tablet Sig: Three (3) Tablet PO QDAY ().
Oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed for pain.
OxyContin 20 mg Tablet Sustained Release 12HR Sig: One (1) Tablet Sustained Release 12HR PO twice a day.
Disp:*60 Tablet Sustained Release 12HR(s)* Refills:*0*   Discharge Disposition: Home With Service  Facility: VNA of Greater [**Location (un) 5871**]/[**Location (un) 6159**]  Discharge Diagnosis: Esophageal cancer Dysphagia   Discharge Condition: HD stable and afebrile.
Discharge Instructions: You were admitted for difficulty swallowing and had a stent place by GI.
Please take all medications as directed.
